Genscript Probio

Overview

GenScript ProBio, established in 2002 and based in the USA, operates within the Biotech and Pharmaceuticals industry, specifically focusing on biologics contract development and manufacturing organization (CDMO) services. The company specializes in preclinical pharmaceutical development services for antibody and protein drugs, as well as contract development and manufacturing services for plasmids, viruses, and mRNA related to gene and cell therapy, including preventive vaccines. GenScript ProBio emphasizes data security and compliance, as highlighted in their Data Security White Paper, which outlines their commitment to quality management systems, including adherence to ISO 9001 certification standards. This certification reflects their dedication to management standardization and supports their operational integrity. The company employs approximately 201 individuals and reported a revenue of 51 million USD, indicating a stable presence in the biotech sector. The limited document corpus suggests a focused expertise in biologics development and a commitment to maintaining high standards in data security and operational practices.

Industry